[Prenatal diagnosis of metabolic hereditary diseases]

Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.

Gene therapy·2003

Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease.

Clinical genetics·2002

Muscle as a putative producer of acid alpha-glucosidase for glycogenosis type II gene therapy.

Human molecular genetics·2002

From gene transfer to gene therapy in lysosomal storage diseases affecting the central nervous system.

Annals of medicine·2001

Gene therapy in lysosomal diseases.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2000

Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation.

Neurology·2000

[In utero treatment of twin-to-twin transfusion syndrome].

La Revue du praticien·2026

[In utero treatment of spina bifida].

La Revue du praticien·2026

[Syphilis and pregnancy].

La Revue du praticien·2026

[Second-line treatments for Parkinson's disease].

La Revue du praticien·2026

[Ageism in healthcare: sad prejudices!]

La Revue du praticien·2026

[Vaccination for pregnant women].

La Revue du praticien·2026

Recent advances in the treatment of chronic liver diseases: focus on MASLD/MASH-related fibrosis.

Clinical and experimental hepatology·2026

Biological age acceleration and extrahepatic multimorbidity in U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cross-sectional study.

Clinical and experimental hepatology·2026

Plasma Metabolites for Identifying Bacterial Infection in Acute-on-chronic Liver Failure: A Prospective Multicenter Study.

Journal of clinical and translational hepatology·2026

Short-Chain Fatty Acids: Microbial Metabolites Driving Gut-Eye Axis Signaling.

Comprehensive physiology·2026

AI-driven diagnostic and prognostic models for metabolic dysfunction-associated steatotic liver disease: insights from clinical, imaging, and multi-omics studies-a scoping review.

Frontiers in medicine·2026

Integrative Multi-omics and Machine Learning Reveal the Therapeutic Mechanisms of Juanyu-Xiaozhi Formula in Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatic Fibrosis via the AP-1/PPARγ/SCD1 Axis.

Journal of clinical and translational hepatology·2026

Related Experiment Videos

[Prenatal diagnosis of metabolic hereditary diseases]

Related Concept Videos

Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.

Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease.

Muscle as a putative producer of acid alpha-glucosidase for glycogenosis type II gene therapy.

From gene transfer to gene therapy in lysosomal storage diseases affecting the central nervous system.

Gene therapy in lysosomal diseases.

Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation.

[In utero treatment of twin-to-twin transfusion syndrome].

[In utero treatment of spina bifida].

[Syphilis and pregnancy].

[Second-line treatments for Parkinson's disease].

[Ageism in healthcare: sad prejudices!]

[Vaccination for pregnant women].

Recent advances in the treatment of chronic liver diseases: focus on MASLD/MASH-related fibrosis.

Biological age acceleration and extrahepatic multimorbidity in U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cross-sectional study.

Plasma Metabolites for Identifying Bacterial Infection in Acute-on-chronic Liver Failure: A Prospective Multicenter Study.

Short-Chain Fatty Acids: Microbial Metabolites Driving Gut-Eye Axis Signaling.

AI-driven diagnostic and prognostic models for metabolic dysfunction-associated steatotic liver disease: insights from clinical, imaging, and multi-omics studies-a scoping review.

Integrative Multi-omics and Machine Learning Reveal the Therapeutic Mechanisms of Juanyu-Xiaozhi Formula in Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatic Fibrosis via the AP-1/PPARγ/SCD1 Axis.

Related Experiment Videos

[Prenatal diagnosis of metabolic hereditary diseases]

Related Concept Videos

Related Articles